Literature DB >> 30512185

B7H6 is a functional ligand for NKp30 in rat and cattle and determines NKp30 reactivity toward human cancer cell lines.

Elisabeth G Bjørnsen1, Lavanya Thiruchelvam-Kyle1, Sigurd E Hoelsbrekken1, Camilla Henden1, Per C Saether1, Preben Boysen2, Michael R Daws1, Erik Dissen1.   

Abstract

NK cells kill cancer cells and infected cells upon activation by cell surface receptors. Human NKp30 is an activating receptor expressed by all mature NK cells. The B7 family member B7H6 has been identified as one ligand for NKp30. Several alternative ligands have also been reported, and the field remains unsettled. To this end, we have identified full-length functional B7H6 orthologs in rat and cattle, demonstrated by phylogenetic analysis and transfection experiments. In cell-cell contact-dependent assays, chimeric NKp30 reporter cells responded strongly to B7H6 in rat and cattle. Likewise, rat NKp30 expressing target cells induced strong activation of B7H6 reporter cells. Together, these observations demonstrate that B7H6 is conserved as a functional ligand for NKp30 in mammalian species separated by more than 100 million years of evolution. B7H6 and NKp30 are pseudogenes in laboratory mice. The rat thus represents an attractive experimental animal model to study the NKp30-B7H6 interaction in vivo. B7H6 was widely expressed among human cancer cell lines, and the expression level correlated strongly with the activation of human NKp30 reporter cells. Furthermore, siRNA knockdown of B7H6 abolished NKp30 reporter responses, suggesting that B7H6 is the major functionally relevant expressed ligand for NKp30 on these cancer cell lines.
© 2018 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  B7H6; Cancer; NK cells; NKp30

Mesh:

Substances:

Year:  2018        PMID: 30512185     DOI: 10.1002/eji.201847746

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  3 in total

1.  Expression of a novel immune checkpoint B7-H6 ligand in human small cell lung cancer.

Authors:  Xiuqin Zhang; Weiguo Xie; Zhiqiang Wang; Shu Song; Yan Qin; Fang Zhang; Fangfang Chen; Liming Cai
Journal:  Ann Transl Med       Date:  2020-05

Review 2.  Natural Killer Cells: Tumor Surveillance and Signaling.

Authors:  Lizeth G Meza Guzman; Narelle Keating; Sandra E Nicholson
Journal:  Cancers (Basel)       Date:  2020-04-11       Impact factor: 6.639

3.  B7-H6, an immunoligand for the natural killer cell activating receptor NKp30, reveals inhibitory effects on cell proliferation and migration, but not apoptosis, in cervical cancer derived-cell lines.

Authors:  Nehla Banu; Annie Riera-Leal; Jesse Haramati; Pablo Cesar Ortiz-Lazareno; Sandeep Surendra Panikar; Blanca Estela Bastidas-Ramirez; Gloria Yareli Gutierrez-Silerio; Fabiola Solorzano-Ibarra; Martha Cecilia Tellez-Bañuelos; Jorge Gutierrez-Franco; Miriam Ruth Bueno-Topete; Ana Laura Pereira-Suarez; Susana Del Toro-Arreola
Journal:  BMC Cancer       Date:  2020-11-10       Impact factor: 4.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.